Newron Receives Positive Opinion for Orphan Medicinal Product Designation for Sarizotan to Treat Patients with Rett Syndrome from the Committee for Orphan Medicinal Products from the European Medicines Agency
Excellent story about transformative medical research underway at Harvard's engineering department in the New Yorker: http://www.newyorker.com/magazine/2014/11/24/print-thyself
Whenever the FDA catches falsified data or unreported side effects, it issues a warning letter to document the bad research. That’s good. But a new study shows...